Study on treatment of H22 liver cancer using 10-HCPT-Ioaded microbubbles and ultrasound-targeted destruction
10.3760/cma.j.issn.1004-4477.2009.09.025
- VernacularTitle:超声靶向辐照载药微泡治疗小鼠H22肝癌的实验研究
- Author:
Pan LI
;
Xing WU
;
Yefeng ZHU
;
Hui ZHANG
;
Yuanyi ZHENG
;
Juan CHENG
;
Zhigang WANG
- Publication Type:Journal Article
- Keywords:
Ultrasonography;
Microbubbles;
Liver neoplasms;
experimental;
Topotecan
- From:
Chinese Journal of Ultrasonography
2009;18(9):801-804
- CountryChina
- Language:Chinese
-
Abstract:
Objective To prepare lipid-coated ultrasound microbubbles containing 10-HCPT(HLM) and explore the antitumor effects on mice xenografed H22 solid tumor using the technique of ultrasound-mediated HLM destruction. Methods Sixty-four tumor-bearing mice were radomly divided into A and B groups. Each group was divided into four groups again and administered respectively by tail vein with HI.M, non-drug-loaded microbubbles,10-HCPT and saline once a day. Ultrasound irradiation was applied on the tumor sites immediately after injection. After 7 days of consecutive treatment, all mice in group A were sacrificed and the tumors were harvested to measure weights. The tumor inhibition rate was calculated by weights. The tumor microvessel density (MVD) was detected by immunohistochemical staining. The tumor growth curve was depicted according to volumes. The survival time of mice in group B was recorded. Results The tumor inhibition rate was the highest in HLM group while this group's MVD was the lowest. Survival time in HLM group and 10-HCPT group were obviously longer compared with the control group,while no statistic difference was observed between the two groups. There was no statistic difference between the group of non-drug-loaded microbubbles and the control group. Conclusions Ultrasound irradiation mediates HLM destruction so that the drug is released from the vihicles at the same time, which can significantly enhance the tumor inhibition effect of 10-HCPT on the H22 tumor. This technique is expected to be adopted as a novel tool for liver cancer chemotherapy.
